Products
Latest Partnered Companies
Projects
Estimated Cost :
$19 million
Summit Biosciences to invest $19 million in it's production at Lexington, Kentucky
Summit Biosciences Inc., a pharmaceutical company focused on nasal spray medicines, is expanding its operation at the University of Kentucky Coldstrea...
Estimated Cost :
€25 million
Evonik Expands Dossenheim and Hanau Sites in Germany
Evonik has announced plans for the expansion of its Dossenheim and Hanau facilities in Germany in order to meet the increasing pharmaceutical demand f...
Estimated Cost :
-
FUJIFILM Diosynth Biotechnologies to Construct New Biocampus in UK
FUJIFILM Diosynth Biotechnologies (FDB)unveiled its plans for the construction of a new BioCampus
Estimated Cost :
€610 million
Sanofi to invest €610 million to Build a New World Class Research Centre
Sanofi plans to build a world class vaccine production site and a new research centre dedicated for the development
Press Release
Lantheus Enters into Strategic Collaboration with Insightec for Use of Microbubbles in Combination with MR-Guided Focused Ultrasound
Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, announced a strategic collaboration with Insightec Ltd., a global healthcare company
Nexus Pharmaceuticals Receives FDA Approval for Succinylcholine Chloride Injection, USP
Nexus Pharmaceuticals announced it has received U.S. Food and Drug Administration (FDA) approval for Succinylcholine Chloride Injection, USP in 200mg/10mL Multiple-Dose Vials. It is an AP-rated generic to QUELICIN™¥.
Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program
Agilex Biolabs, Australia's most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi on the announcement of the first-ever application of click chemistry in humans, with the launch of the Company's lead clinical candidate, SQ3370. Shasqi is the first Y Combinator-backed biotech company
Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications
Releviate™ Therapeutics, a bio-pharmaceutical company addressing the needs of patients suffering from chronic pain, signs an exclusive license for two patent pending human monoclonal antibodies developed by researchers at the University of California, Riverside and Duke University.
Events
Annual Radiology Meeting
International Conference and Expo on Nutrition, Food Safety and Food Technology
Articles
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Next-Generation Biological Therapeutics Discovery & Development
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
Advertisements
See your banner here...
